Author Archive Solchem

Product stability: long shelf life

In traditional probiotic products, a large number of viable cells die during exposure to environmental conditions. Megaflora 9 evo matrix protects the bacteria against unfavourable conditions and allows to store the product at room temperature. The matrix significantly improves the stability giving a long shelf life.

The effectiveness of a probiotic product depends on the total viable bacterial count in the product. For this reason, the half-life of a probiotic products is based on the total of viable cells during storage time. The best method to measure the half-life of the product is by a real time stability test (RTS), where the bacterial count is expressed as colonies forming units (cfu) per gram, meaning cfu as living and viable bacteria.

The recent development of Megaflora 9 evo makes not possible to have a real shelf life under RTS test. However, it was carried out an accelerated stability test at 37° C ± 2° C for 4 weeks. This study considered the maximum temperature at which no bacterial damage occurs, but allows to check the stability in a short period that can be extrapolated to a situation of 25ºC stability.

Megaflora 9 evo samples were tested at T0 to T2, T3 and T4 times. The result shows that the concentration of bacteria was stable during all the time with a concentration that exceeded one billion per gram, which is the guaranteed concentration at the end of the shelf life of the product.

Megaflora 9 evo has the same stable behaviour than its probiotic and prebiotic predecessor, which has a stability of 48 months in RTS test.

The accelerated stability study has demonstrated that Megaflora 9 evo has a comparable stability than its predecessor and, therefore, at room temperature the same behaviour is expected. To prove this, a RTS test on Megaflora 9 evo is on going.

Accelerated stability test at 36 ° C for 4 weeks, of Megaflora 9 evo.

Gastrointestinal survival

Surviving the path of the gastrointestinal tract is the first basic function of a probiotic based product. The more bacteria survive the passage through the gastrointestinal tract, better will be the effect on our body.

When bacteria are unprotected, a large number of viable cells is destroyed as a result of the low pH of the stomach, enzymes and digestive fluids.

In traditional products based on probiotics, a large quantity of bacteria are destroyed by the fluids of the GI tract. It is estimated that the survival of the bacteria that are ingested without any protection ranges from 0.5 to 1%, when they reach the intestine, meaning that, for example, from a concentration of 100,000 million bacteria per gram of product supplied, only 1,000 million bacteria will reach the intestine alive.

Probiotic blend: with 100.000 million bacteria/g (1 x 1011)
1% de survival = 1.000 million viable bacteria (1 x 109)

Megaflora 9 evo: with 2.000 million bacteria/g (2 x 109)
minimum 90% survival = more than 1.800 million viable bacteria (>1,8 x 109)

The technology used in Megaflora 9 evo production protects the bacteria against the acidic conditions of the stomach and keeps bacteria alive. This technology ensures a survival of more than the 90% of the initial concentration. This explains why the concentration of bacteria in Megaflora 9 evo does not need to be as high as other commercial preparations, in which an important part of the bacteria suffer a high mortality during their transit through the GI passage.

In vitro model that simulates the digestive system showing compartmentalisation, pH, enzyme and bile secretion over 6 hours digestion.

Gastrointestinal survival can be studied on a in vitro model developed by the University of Maastricht. This model simulates the passage of bacteria through the GI tract and allows to calculate the survival of the strains, and its resistance to gastric acid, pepsin, pancreatin and bile salts.

The model imitates the compartmentalization and timing of transit in every part of the GI tract, regulating the secretion of pH, addition of enzymes and secretion of bile onto the sample to be studied.

The experiment is run at 37 ° C and the total count of bacteria in the sample is measured at four different times:

  • After rehydration of the sample (T = ‘Ah)
  • After simulating the passage through the stomach (T = 1’Ah)
  • Approximately 1.5 hours after addition of bile and pancreatin (T = 3h)
  • At the end of the digestion period (T = 6h)

Living and viable bacteria count (cfu/g) at 4 times in the GI survival model test: T = ‘Ah, T = 1’Ah, T = 3h and T =6h

Megaflora 9 evo clearly shows that after the passage of GI tract, the number of living bacteria (cfu/g) was stable with a minimum of loss. This initial decrease in the number of bacteria is better than usual expected in probiotic products.

A part of the impact which might result from the survival in the GI tract, the addition of certain ingredients to the product can damage bacteria so that, although they survive, cannot reach its optimal activity level. These cells can be counted as viable, but are not active and therefore the product loses its effectiveness.

Increased metabolic activity

After passing through the GI tract, the probiotic bacteria reach the small intestine, where they have to be effective at the right time and in the right place.

Metabolic or biological activity is one of the most important parameters that determines the quality of a probiotic based product. In fact, it is even more important than the amount of bacteria in the product since, from a metabolic point of view, it is useless to have a very high number of bacteria in the intestine if they are not viable.

The lactic acid production can be used as an indicator of the activity of the product since is a specific feature of probiotic activity and one of the actions that promotes health. It can be state without no doubt that the greater the production of lactic acid, the higher metabolic activity of bacteria or mixture is. Hence, measuring the production of lactic acid is considered a good method for determining activity of the probiotic strains.

The lactic acid production must be measured over time and always after a simulation of passage through the gastrointestinal tract.

When comparing the average production of lactic acid of Megaflora 9 evo with two other similar prebiotic and probiotic mixtures in concentration and gastroresistance, Megaflora 9 evo showed that after 4 hours the producing lactic acid activity was far superior.

Activity producing lactic acid of Megaflora 9 evo compared with other similar marketed probiotic mixtures with the same capacity of gastroresistance.

This result establishes that Megaflora 9 evo contains living, viable and active bacteria after GI passage.

Megaflora 9 evo: Clinical evidence

Two separate pilot studies have determined the in vivo survival of Megaflora 9 evo bacteria.

Survival of Bifidobacterium

In the first study, the survival of Bifidobacterium was tested in 23 medical students from the University of Wageningen. The study was randomized double-blind controlled versus placebo with a dosage of 4 g of Megaflora 9 evo or placebo per day divided in 2 doses for 7 days.

At the beginning and at the end of the study stool samples were analyzed by PCR, DGGE and FISH. The results showed that students who consumed Megaflora 9 evo presented a clear difference in the population of bifidobacteria in the faeces compared to the placebo group, evidenced by the DGGE profile.

The image shows the DGGE results of nine students, 6 consuming Megaflora 9 evo (M9E) and 3 consuming placebo (P). It can be appreciated that students M9E-1 and M9E-7 presented specific markers for bifidobacteria at day 7 after consumption of Megaflora 9 evo compared with baseline (red circles).

Profile DGGE to identify the presence of bifidobacteria in faecal samples from students at baseline and 7 days of consuming Megaflora 9 evo or placebo. Red circles show clear differences in the presence of markers in bifidobacteria group students Megaflora 9 evo.

These results demonstrate the survival of Bifidobacterium of Megaflora 9 evo in the gastrointestinal tract.

Survival of Lactobacillus

In the second study, 100 medical students from the University of Maastricht participated in a randomized double-blind controlled study versus placebo. The students were equally divided into two groups that were given Megaflora 9 evo or placebo.

The duration of the study was 8 days during which students consumed a dose of 3.8 g of Megaflora 9 evo or placebo divided by 2 times a day. The aim of the study was to check the survival of lactobacilli present in the faeces after ingestion.

The result showed a significant difference of lactobacilli in the faeces of students who consumed Megaflora 9 evo, demonstrating the survival of the bacteria after the GI passage.

Results of the clinical study in 100 medical students on the survival of lactobacilli. Department of Microbiology at the University of Maastricht

Key points

Megaflora 9 evo is a unique product in its category as it is the result of the development and research that has been carried out to obtain a composition that has a broad spectrum of application:

  • It is based on the concept of multi-strain and multi-species.
  • It has a 4 year stability at room temperature (25° C).
  • It has a high survival in the gastrointestinal tract.
  • It has a high metabolic activity of lactic acid production.
  • It is able to inhibit the growth of pathogenic flora (Clostridium, Candida, E. coli, S. aureus, Salmonella, etc.).
  • It is able to maintain the barrier effect protecting the intestinal epithelium against damage from external agents.
  • It is able to stimulate the production of IL-10 to influence by both mechanisms immunomodulation.

In addition Megaflora 9 evo present also these features:

  • Convenient dosage of 1 to 2 g per day.
  • Total solubility in water, milk and yogurt.
  • Safe consumption: allergen free including gluten-free and it may be recommended from 1 year of baby life.

FAQS

The next generation of broad-spectrum probiotics for our second brain.

Intestinal Flora Balance


Why Megaflora 9 evo?

  • Has a long shelf life: 4 years
  • It is stored at room temperature.
  • High gastrointestinal survival (the bacteria exceeds the ACID pH of the stomach and alkaline pH of the small intestine).
  • Survival of the bacteria at the level of 90 per cent to the upper intestine, guaranteeing their activity.
  • Short time of hydration of bacteria: 1 minute
  • Broad spectrum of treatment and prevention of eating disorders

What are the characteristics of the matrix of Megaflora 9 evo?

  • Stability of the mixture to 4 years.
  • Conservation at room temperature.
  • Gastro resistance.
  • Acceleration in the activation of the bacteria.

Why is the amount of lactic acid important?

Because it maintains the pH of the gut and is used for the control of pathogenic flora.

What does the bacteria in stool prove?

The presence of an increase in bacteria in the stool after consuming Megaflora 9 evo demonstrates that it is produced a growth of the lactofermentative bacteria in the intestine.

Why Megaflora 9 evo has a low concentration of bacteria?

  • What is important is not the amount of bacteria that taken, but the amount and form in which they arrive alive to the intestine.
  • Example of a normal mix with the best survival results:
    • 1 g of probiotic 100,000,000,000 with a concentration of bacteria/g and a survival rate of 7% = 7,000,000,000 bacteria arrive at the intestine.
    • 1 g of Megaflora 9 evo with a concentration of 2,000,000,000 bacteria/g and a superior survival to 90% = more than 1,800,000,000 bacteria arrive alive to the intestine.

Why is it stored at room temperature (25ºC)?

Thanks to the matrix in which the probiotic strains are included.

Is It Safe?

The bacterial strains containing  Megaflora 9 evo possess the qualification of QPS (Qualified Presumption of Safety).

Can children take it?

Yes, older than one year.

Can pregnant women take it?

Yes, with a doctor’s approval.

Where do probiotics act?

In the intestine, at three levels:

  1. Interaction probiotics-microorganisms
  2. Interaction probiotics-intestinal mucosa
  3. Interaction probiotics-immune system

Why is it important the fact that Megaflora 9 evo bacteria are bound to a matrix?

The matrix acts as a growth substrate for the bacteria and provides all the features already described above.

Are Megaflora 9 evo bacteria alive, dead, microencapsulated?

They are alive in a state of latency, activated and revived by contact with a liquid or yogurt.

Why is it important to have an intestinal mucosa in good conditions?

Our intestine is known as the second brain because the processes of absorption and control of substances that carries out influence decisively in the person’s health.

Can you mix Megaflora 9 evo with other ingredients?

Yes, but you should consulted it, as some ingredients may have an antibiotic action, such as copper.

Does it have any allergen to declare?

Megaflora 9 evo does not contain any allergen.

Can Megaflora 9 evo be encapsulated?

Yes, it can be encapsulated, but it is not recommended to compressed it, unless it is used a recovering that guarantees the viability of the bacteria.

Can this combination be used to ferment food?

Megaflora 9 evo contains alive, active and dairy fermentative bacteria, so it could be used in the production of yogurt.

What is the recommended dose?

Given the concentration of 2,000,000,000 million of bacteria/g, it is recommended a dose of 1 g of Megaflora 9 evo for the maintenance and 2 g in the case of treatment.